De Burlo Group’s Exact Sciences EXAS Stock Holding History

De Burlo Group’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-8,000	Closed	-$237K	–	105
2015 Q2	$237K	Sell	8,000 -87,400	-92%	-$2.2M	0.05%	102
2015 Q1	$2.1M	Sell	95,400 -301,500	-76%	-$7.65M	0.42%	68
2014 Q4	$10.9M	Buy	396,900 +38,000	+11%	+$925K	2.2%	11
2014 Q3	$6.96M	Buy	358,900 +104,700	+41%	+$1.92M	1.54%	26
2014 Q2	$4.33M	Buy	+254,200	New	+$3.5M	0.98%	45

Other funds holding EXAS

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

De Burlo Group's EXAS Position: Q3 2015 in Review

De Burlo Group sold out of Exact Sciences (EXAS) in Q3 2015, closing a stake of 8,000 shares — an estimated $237K sold.

De Burlo Group first reported a position in EXAS in Q2 2014 and held it in 5 quarters. The position peaked at $10.9M in Q4 2014. 191 funds tracked by Wall St. Rank hold EXAS as of Q3 2015.

De Burlo Group reported no remaining Exact Sciences position as of Q3 2015 after selling out during the quarter.
De Burlo Group sold 8,000 Exact Sciences shares in Q3 2015, an estimated $237K.
De Burlo Group first reported a position in Exact Sciences in Q2 2014 and held it in 5 quarters.
De Burlo Group's Exact Sciences position peaked at $10.9M in Q4 2014.
191 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2015.

Based on De Burlo Group's 13F filing for Q3 2015, filed 5 Nov 2015.